Comment on

• c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.

  Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M, et al. Muss HB, et al. N Engl J Med. 1994 May 5;330(18):1260-6. doi: 10.1056/NEJM199405053301802. N Engl J Med. 1994. PMID: 7908410 Clinical Trial.
• Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.

  Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR, et al. Wood WC, et al. N Engl J Med. 1994 May 5;330(18):1253-9. doi: 10.1056/NEJM199405053301801. N Engl J Med. 1994. PMID: 8080512 Clinical Trial.